Qianmao Liang

PhD student

350 Shushanhu Road, Hefei, Anhui, 230031, P.R. China

Tel:+86-551-65593617

Email: liangqianmaoandlqm@126.com

 

 

EDUCATION BACKGROUND

 

M.S. (2013~present), Organic Chemistry School of Chemistry and Materials Science, University of Science and Technology of  China

B.S. (2007~2012), Clinical Pharmacology School of Medicine, Anhui Medical University, China

 

PUBLICATIONS

 

  1. Qianmao Liang#, Yongfei Chen#, Kailin Yu#, Cheng Chen#, Shouxiang Zhang#, Aoli Wang, Wei Wang, Hong Wu, Xiaochuan Liu, Beilei Wang, Li Wang, Zhenquan Hu, Wenchao Wang, Tao Ren, Shanchun Zhang, Qingsong Liu, Cai-Hong Yun*, Jing Liu*. Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor. Eur. J. Med. Chem. 2017, 131: 107-125.
  2. Qiang Wang#, Feiyang Liu#, Beilei Wang#, Fengming Zou#, Ziping Qi, Cheng Chen, Kailin Yu, Chen Hu, Shuang Qi, Wenchao Wang, Zhenquan Hu, Juan Liu, Wei Wang, Li Wang, Qianmao Liang, Shanchun Zhang, Tao Ren, Qingsong Liu*,Jing Liu*. Discovery of 4-Methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl) phenyl)-3-((1-nicotinoylpiperidin-4-yl)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding. J. Med. Chem. 2017, 60: 273-289.

 

PATENTS

 

  1. 1.发明名称:一种新型布鲁顿酪氨酸激酶不可逆抑制剂
    发明人:刘静, 刘青松, 梁前茅,陈永飞,陈程,王傲莉,吴宏,余凯琳,王伟,胡晨,王文超,亓爽,王蓓蕾,王黎
    专利受理号:201610084082.1